233 related articles for article (PubMed ID: 15482470)
1. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
[TBL] [Abstract][Full Text] [Related]
2. TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis.
Viard-Leveugle I; Gaide O; Jankovic D; Feldmeyer L; Kerl K; Pickard C; Roques S; Friedmann PS; Contassot E; French LE
J Invest Dermatol; 2013 Feb; 133(2):489-98. PubMed ID: 22992806
[TBL] [Abstract][Full Text] [Related]
3. [Epidermal necrolysis: mechanisms of keratinocyte apoptosis].
Roujeau JC; Gélard K; Bensussan A
Med Sci (Paris); 2006 Feb; 22(2):188-91. PubMed ID: 16457761
[TBL] [Abstract][Full Text] [Related]
4. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
de Araujo E; Dessirier V; Laprée G; Valeyrie-Allanore L; Ortonne N; Stathopoulos EN; Bagot M; Bensussan A; Mockenhaupt M; Roujeau JC; Tsapis A
Exp Dermatol; 2011 Feb; 20(2):107-12. PubMed ID: 21255088
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
Arnold R; Seifert M; Asadullah K; Volk HD
J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
[TBL] [Abstract][Full Text] [Related]
6. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
[TBL] [Abstract][Full Text] [Related]
7. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
[TBL] [Abstract][Full Text] [Related]
8. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.
Nassif A; Bensussan A; Dorothée G; Mami-Chouaib F; Bachot N; Bagot M; Boumsell L; Roujeau JC
J Invest Dermatol; 2002 Apr; 118(4):728-33. PubMed ID: 11918724
[TBL] [Abstract][Full Text] [Related]
9. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
Nassif A; Bensussan A; Boumsell L; Deniaud A; Moslehi H; Wolkenstein P; Bagot M; Roujeau JC
J Allergy Clin Immunol; 2004 Nov; 114(5):1209-15. PubMed ID: 15536433
[TBL] [Abstract][Full Text] [Related]
10. Review of Toxic Epidermal Necrolysis.
Harris V; Jackson C; Cooper A
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999358
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Khalili B; Bahna SL
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
[TBL] [Abstract][Full Text] [Related]
12. Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yang Y; Li F; Du J; Shen Y; Lin J; Zhu X; Luo X; Liang J; Xu J
Australas J Dermatol; 2017 Aug; 58(3):e61-e67. PubMed ID: 27040133
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of case-control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis.
Stewart TJ; Farrell J; Frew JW
Australas J Dermatol; 2024 Jun; ():. PubMed ID: 38831709
[TBL] [Abstract][Full Text] [Related]
14. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.
Correia O; Delgado L; Barbosa IL; Campilho F; Fleming-Torrinha J
J Am Acad Dermatol; 2002 Jul; 47(1):58-62. PubMed ID: 12077582
[TBL] [Abstract][Full Text] [Related]
15. Blister fluid cytokines in cutaneous inflammatory bullous disorders.
Rhodes LE; Hashim IA; McLaughlin PJ; Friedmann PS
Acta Derm Venereol; 1999 Jul; 79(4):288-90. PubMed ID: 10429986
[TBL] [Abstract][Full Text] [Related]
16. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
[TBL] [Abstract][Full Text] [Related]
18. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
Konur A; Schulz U; Eissner G; Andreesen R; Holler E
Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
[TBL] [Abstract][Full Text] [Related]
19. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
20. Decisive role of tumor necrosis factor-α for spongiosis formation in acute eczematous dermatitis.
Kerstan A; Bröcker EB; Trautmann A
Arch Dermatol Res; 2011 Nov; 303(9):651-8. PubMed ID: 21553284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
